Healthcare & Life Sciences
NGM Bio
United Stateswww.ngmbio.com/
NGM Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2
Investors
About NGM Bio
Based in the United States, NGM Bio is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
NGM Bio is a clinical-stage biopharmaceutical company developing first-in-class biologic medicines targeting the GDF15 pathway to treat conditions such as hyperemesis gravidarum and cancer cachexia.
Explore NGM Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.